Navigation Links
Neurological in Medical Technology

Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease

... Banner Alzheimer's Institute, Barrow neurological Institute, Sun Health Research Institute, ... www.banneralz.org . About Barrow neurological Institute Barrow neurological Institute of St. Joseph's Hospital and ...

Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharma's Product Class

... (CMT) is one of the most common inherited neurological disorders, with typical symptoms usually emerging ... into the Drosophila genome, the flies develop neurological defects that correspond to CMT in humans. While ... mutations in the tRNA synthetase gene disrupt the neurological system of a complex organism, this study showed ...

Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)

... Epilepsy is one of the most common neurological diseases, affecting approximately one in 100 ... Epilepsy is one of the most common neurological diseases, affecting approximately 1 in 100 people(6). Epilepsy is a chronic neurological disease characterised by abnormal discharges of ...

ADHD Genes Found; Known to Play Roles in Neurodevelopment

... also altered genes important in psychological and neurological functions such as learning, behavior, synaptic ... involved in ADHD may also be common to other neurological conditions, say the researchers. Likewise, there ... also occur in autism, schizophrenia and other neurological disorders. This overlap was not surprising, said ...

Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries

... Contreras, and Dr. J. Brett Dietze of Texarkana neurological Associates are utilizing the new procedure that ... also an expectation held unanimous by Texarkana neurological Associates. This surgical approach is without ... adding time to the surgery." Texarkana neurological Associates are establishing themselves as the ...

Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults

... Director of Clinical Epilepsy Research at Barrow neurological Institute in Phoenix. "Vimpat(R) can help ... The unmet medical need Epilepsy is a common neurological disorder that can be life long, and is difficult ... About Epilepsy Epilepsy is a chronic neurological disorder affecting approximately 50 million ...

Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients

... leader in using stem cells to effectively treat neurological disorders, announced today six new globally ... the increasing numbers of those suffering from neurological illnesses worldwide, but restricted from ... under TP Biomedical Ltd., is a world-class neurological treatment facility in Beijing that is gaining ...

Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder

... of the post-TCD group. Cases of stroke or other neurological events were identified from the clinical ... or hemorrhagic), not overt stroke (other neurological event), and indeterminate (unable to classify ... who experienced overt stroke, six with other neurological events, and one who had an indeterminate event. ...

New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer

... studies on tea polyphenols, including research on neurological health, genetic susceptibility to cancer, ... cancers, type II diabetes, and help maintain neurological function." Theanine in Tea Increases Attention ... of action on a cellular level on maintaining neurological health. Mandel, who has been studying the ...

Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting

... that were designed to measure changes in neurological health. Quantitative sensory testing (QST) using ... to measure a clinically meaningful change in the neurological status of patients with DN over time. NIS-LL ... in a number of quantitative measures of neurological health," said Edward Lanphier, Sangamo's ...

Immunosyn Corporation Releases SF-1019 Study Results

... initial study and the results were extraordinary. neurological scores on average were elevated from 52.5 before ... form of therapy for treatment of progressive neurological auto-immune and inflammatory conditions for ... disorders such as Multiple Sclerosis (MS) and neurological disorders such as Chronic ...

Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help

... and vegetables support the body in fighting neurological decline through antioxidant mechanisms associated ... lower incidence rates of age-related neurological disorders among Asians than in Europeans ... cancers, type II diabetes, and help maintain neurological function. Researchers are finding out exactly ...

More Gene Mutations Linked to Autism Risk

... which can disrupt the production of proteins necessary for normal neurological development. "We focused on changes in the exons of ... BZRAP1 and MDGA2 - thought to be important in synaptic function and neurological development, respectively. Interestingly, key variants of these genes were ...

Neurocrine Biosciences Presents Elagolix Data

... Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine related diseases and disorders. Our product candidates ... depression, pain, diabetes, benign prostatic hyperplasia (BPH) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. ...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

... is an important goal," said Lawrence Recht, MD, Professor of Neurology and neurological Sciences, Stanford University Medical Center. "The results of these ... or improved Karnofsky performance status and stable or improved 10-item neurological Examination Scores. On the primary endpoint (during weeks two through ...

Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimer's Disease

... diseases of memory. Its primary mission is to accelerate the transfer of neurological discoveries from the lab to the doctor's office where it can benefit patients who suffer from neurological and psychiatric diseases. BRNI is operated in alliance with West ...

New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting

... About Parkinson's disease Parkinson's disease is a progressive neurological disorder that affects nearly one million people in the U.S. It is the second most common chronic neurological disorder in older adults after Alzheimer's. Every nine minutes someone is ...

PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)

... (ear, nose and throat), gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures; Receipt of European CE Mark approval for the ... and reconstructive, ENT, gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures in the United States, and for use in general surgery ...

Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain

... Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some ... prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, ....

Key Protein May Lead to Faster Acting Anti-Depression Drugs

... cognizant that Parkinson's disease is the world's second most prevalent neurological disease after Alzheimer's, The Michael Stern Parkinson's Research ... and provide better treatments, as well as fund research into related neurological diseases that can lead to a Parkinson's cure and, through education of ...

ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease

... Allergan, to discover and develop new therapeutics in the areas of pain, neurological diseases and ophthalmology. This collaboration provides ongoing research ... Presented at the 12th congress of the European Federation of neurological Societies; 23-26 August, 2008; Madrid, Spain [3] WHO 2001. ...

Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test

... Gehrig's (ALS) diseases from "normal" individuals and patients with other neurological disorders. In so doing, the test helps the physician make appropriate ... discriminates between disease and controls, among different types of neurological diseases, with neurodegenerative disease fitting within Transgenomic's ...

VA-NIH Study Offers Hope for Parkinson's Patients

... by VA's Cooperative Studies Program and the National Institute of neurological Disorders and Stroke, part of the National Institutes of Health. ... the DBS system used in the study. Parkinson's disease, a progressive neurological disorder, affects some 1.5 million Americans, with 50,000 new cases ...

Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia

... is believed to be a central nervous system condition, resulting from neurological changes in how the brain perceives and responds to pain. In addition to ... commitment to improving care for patients with serious psychiatric and neurological conditions through innovative treatments and distinctive and valuable ...

Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

... bipolar disorder, PTSD, mild cognitive impairment and schizophrenia) and neurological diseases (e.g. Parkinson's and Alzheimer's diseases). Furthermore, ... bipolar disorder and other mood disorders, Alzheimer's disease (AD) and neurological disorders. For example, sleep disturbances in patients with Alzheimer's ...

PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications

... (ear, nose and throat), gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures. The company also announced that it has initiated a ... and reconstructive, ENT, gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures in the United States. For more information, please ...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... Syndrome (RPLS) in patients receiving VELCADE. RPLS is a rare, reversible, neurological disorder which can present with seizure, hypertension, headache, lethargy, confusion, blindness, and other visual and neurological disturbances. VELCADE is associated with thrombocytopenia and neutropenia. ...

Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS)

... About Teva Neuroscience Teva Neuroscience is the branded neurological products franchise of Teva Pharmaceutical Industries Ltd. and is responsible for the development, registration and marketing for Teva's branded neurological products in North America. Teva Neuroscience has administrative, ...

New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy

... with existing anti-epileptic agents." Epilepsy is one of the most common neurological diseases affecting almost one in 100 people.(8) Treatment of partial ... partial seizures and their treatment Epilepsy is one of the most common neurological diseases, affecting almost 1 in 100 people.(8) Treatment of partial ...

ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease

... said Stanley Appel, M.D., co-founder & co-director of the Methodist neurological Institute in Houston, Texas. At the time of this announcement, ALS TDI ... blood donations and clinical information from ALS patients; Methodist neurological Institute, University of California - Irvine, and Mount Sinai Medical ...

Anavex presents neuroprotective effects of Anavex 1-41 at the International Conference on Alzheimer's Disease 2008

... and development of novel drug targets for the treatment of cancer and neurological diseases such as Alzheimer's, epilepsy and depression. The company's ... involves the development of novel and original drug candidates that target neurological and neurodegenerative diseases (Alzheimer's disease, epilepsy, depression, ...

Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma

... Syndrome (RPLS) in patients receiving VELCADE. RPLS is a rare, reversible, neurological disorder which can present with seizure, hypertension, headache, lethargy, confusion, blindness, and other visual and neurological disturbances. VELCADE is associated with thrombocytopenia and neutropenia. ...

VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma

... Syndrome (RPLS) in patients receiving VELCADE. RPLS is a rare, reversible, neurological disorder which can present with seizure, hypertension, headache, lethargy, confusion, blindness, and other visual and neurological disturbances. VELCADE is associated with thrombocytopenia and neutropenia. ...

New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma

... Syndrome (RPLS) in patients receiving VELCADE. RPLS is a rare, reversible, neurological disorder which can present with seizure, hypertension, headache, lethargy, confusion, blindness, and other visual and neurological disturbances. VELCADE is associated with thrombocytopenia and neutropenia. ...

Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research

... Zhuang of the Surgical Neurology Branch (SNB), National Institute of neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) and its ... abnormalities of common human cancers. About the National Institute of neurological Disorders and Stroke (NINDS), (NIH): NINDS (http://www.ninds.nih.gov ) ...

FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment

... worldwide are affected by MS, the most common non-traumatic cause of neurological disability in young people. Regulatory filings for FTY720 are expected in ... presents in relapsing forms involving acute self-limiting attacks of neurological dysfunction (or "relapses") followed by complete or partial restoration of ...

Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack

... that induced hypothermia reduced mortality and improved long-term neurological function. Based on these and other results, the American Heart Association ... and to potentially lessen or prevent associated injuries such as adverse neurological outcomes. For more information about Cardium's InnerCool subsidiary and ...

Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma

... Syndrome (RPLS) in patients receiving VELCADE. RPLS is a rare, reversible, neurological disorder which can present with seizure, hypertension, headache, lethargy, confusion, blindness, and other visual and neurological disturbances. VELCADE is associated with thrombocytopenia and neutropenia. ...

Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting

... reports of RPLS in patients receiving VELCADE. RPLS is a rare, reversible, neurological disorder which can present with seizure, hypertension, headache, lethargy, confusion, blindness, and other visual and neurological disturbances. VELCADE is associated with thrombocytopenia and neutropenia. ...

New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma

... reports of RPLS in patients receiving VELCADE. RPLS is a rare, reversible, neurological disorder which can present with seizure, hypertension, headache, lethargy, confusion, blindness, and other visual and neurological disturbances. VELCADE is associated with thrombocytopenia and neutropenia. ...
Other Contents
(Date:10/15/2014)... ability to assess the pandemic risk from strains of ... must not allow ourselves to become complacent that the ... consortium of scientists. , Influenza pandemics arise when a ... to develop widespread immunity – spreads in the human ... past 100 years, the worst of which – the ...
(Date:10/15/2014)... 15, 2014 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market releases photos and video of ... on Monday October 13 th . Gino ... and angel investor Mr. Chad A. Verdi rang ... NXT-ID thanked his investors and employees "for their work and dedication ...
(Date:10/14/2014)... Ohio (Oct. 14, 2014)—It,s been millions of years since ... a team led by Ohio University scientists is breathing ... model airflow through dinosaur snouts. The research has important ... only breathe but to enhance the sense of smell ... ,nosy, animals," said Ohio University doctoral student Jason Bourke, ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
(Date:10/25/2014)... safe and sound is one of the best Halloween treats ... and goody bags have reflective strips that improve visibility to ... Meadowlands Hospital Medical Center in Secaucus, N.J. Trick-or-treaters ... Davis said. He offers these others tips: ... small area of skin first to ensure it doesn,t cause ...
(Date:10/25/2014)... Background: , In 1998 Bob Savage founded the Connecticut ... the field of establishing recovery community organizations. Bob had ... he retired, he set out to answer a couple questions ... , 1. Where are the people in recovery when ... Can the recovery community be organized to advocate for issues ...
(Date:10/25/2014)... Minnesota (PRWEB) October 25, 2014 ... testing firm which verifies IT-accessibility for disabled users ... Access Approved® logo to Mackin Educational Resources ... digital resource management system and to the Minnesota ... the "Own Best Medicine" website. ...
(Date:10/25/2014)... QueenBeeTickets.com has a variety of tickets for ... prices. Bob Seger & The Silver Bullet Band tickets ... are going on sale October 25 and are expected ... browse the selection of tickets for Bob Seger & ... singer is touring North America beginning next month, and ...
(Date:10/25/2014)... New York, New York (PRWEB) October 25, 2014 ... of transvaginal mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) ... multidistrict litigation underway in U.S. District Court, Southern ... Motion for Summary Judgment on Punitive Damages in ... Florida plaintiffs. In a ruling issued on October ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 3Health News:QueenBeeTickets.com Features Bob Seger & The Silver Bullet Band Tickets for Charleston Civic Center, Huntington Center, and Nationwide Arena at Reduced Prices 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4
Other TagsOther Tags